+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Angioedema Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 120 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5707251
Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. In the next few years the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan. Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.

The treatments studies for analyzing the overall angioedema treatment market are Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents and blood protein controllers. Market size and forecast for each of these segments for the period 2020-2030 are provided in this study along with respective CAGRs for the forecast period 2022-2030. This report also highlights information about major clinical trial candidates under scrutiny for angioedema treatment. These candidates are categorized corresponding to their trial phase, namely phase I, phase II and phase III.

Market size and forecast for these regional and country level markets are presented in this study for the period 2020-2030. Market growth rates for the forecast period 2022-2030 are also included in this report, considering 2021 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global angioedema treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global angioedema treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in angioedema treatment market.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Angioedema Treatment market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Angioedema Treatment market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment

  • Antihistamines
  • Cortecosteroids
  • Autoimmune Drugs
  • Antifibrinolytic Agents
  • Blood Protein Controllers

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Angioedema Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Angioedema Treatment market?
  • Which is the largest regional market for Angioedema Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Angioedema Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Angioedema Treatment market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Angioedema Treatment Market
2.2. Global Angioedema Treatment Market, By Treatment, 2021 (US$ Million)
2.3. Global Angioedema Treatment Market, By Geography, 2021 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2021
3. Angioedema Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Angioedema Treatment Market Vendors
3.2. Strategies Adopted by Angioedema Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030
4. Angioedema Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Angioedema Treatment Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Antihistamines
5.3.2. Cortecosteroids
5.3.3. Autoimmune Drugs
5.3.4. Antifibrinolytic Agents
5.3.5. Blood Protein Controllers
6. North America Angioedema Treatment Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
6.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
7. UK and European Union Angioedema Treatment Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.5. France
7.3.1.5.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
8. Asia Pacific Angioedema Treatment Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.3. India
8.3.1.3.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
9. Latin America Angioedema Treatment Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
9.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
10. Middle East and Africa Angioedema Treatment Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
10.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
11. Company Profile
11.1. AstraZeneca plc
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. F. Hoffmann-La Roche AG
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Valeant Pharmaceuticals International.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Merck & Co.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Dyax Corp
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. CSL Behring
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Pharming Group
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. ViroPharma
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Other Notable Players
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
List of Figures
Figure 1 Global Angioedema Treatment Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Angioedema Treatment Market: Quality Assurance
Figure 5 Global Angioedema Treatment Market, By Treatment, 2021
Figure 6 Global Angioedema Treatment Market, By Geography, 2021
Figure 7 Market Geographical Opportunity Matrix - Global Angioedema Treatment Market, 2021
Figure 8 Market Positioning of Key Angioedema Treatment Market Players, 2021
Figure 9 Global Angioedema Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 10 Global Angioedema Treatment Market, By Treatment, 2021 Vs 2030, %
Figure 11 U.S. Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 12 Canada Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 13 Rest of North America Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 14 UK Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 15 Germany Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 16 Spain Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 17 Italy Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 18 France Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 19 Rest of Europe Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 20 China Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 21 Japan Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 22 India Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 23 Australia Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 24 South Korea Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 25 Rest of Asia Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 26 Brazil Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 27 Mexico Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 28 Rest of Latin America Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 29 GCC Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 30 Africa Angioedema Treatment Market (US$ Million), 2020 - 2030
Figure 31 Rest of Middle East and Africa Angioedema Treatment Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 2 North America Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 3 U.S. Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 4 Canada Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 5 Rest of North America Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 6 UK and European Union Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 7 UK Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 8 Germany Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 9 Spain Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 10 Italy Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 11 France Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 12 Rest of Europe Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 13 Asia Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 14 China Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 15 Japan Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 16 India Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 17 Australia Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 18 South Korea Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 19 Latin America Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 20 Brazil Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 21 Mexico Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 22 Rest of Latin America Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 23 Middle East and Africa Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 24 GCC Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 25 Africa Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
Table 26 Rest of Middle East and Africa Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)

Companies Mentioned

  • AstraZeneca plc
  • F. Hoffmann-La Roche AG
  • Valeant Pharmaceuticals International.
  • Merck & Co.
  • Dyax Corp
  • CSL Behring
  • Pharming Group
  • ViroPharma